JAKE UMBARGER: Open Payments
NPI 1073257994 · SLC, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 29 payments from 7 companies in 2025. Trend: 2023 $572 · 2024 $935 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 14 | $193 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $117 |
| ABBVIE INC. | 4 | $73 |
| PFIZER INC. | 3 | $44 |
| Averitas Pharma Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
Products named: Belbuca, RELISTOR, NURTEC ODT, UBRELVY, QULIPTA, QUTENZA, SYNCHROMEDII, JOURNAVX.
Industry payments across UT — which companies pay providers there.
